NVO – Novo Nordisk A/S
Novo Nordisk A/SNVO
$48.74Name : Novo Nordisk A/S
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $216,732,991,488.00
EPSttm : 3.67
Novo Nordisk A/S
$48.74
0.77%$0.38Float Short %
0.94
Margin Of Safety %
6
Put/Call OI Ratio
0.84
EPS Next Q Diff
4.17
EPS Last/This Y
17.48
EPS This/Next Y
1.05
Price
48.73
Target Price
58.65
Analyst Recom
2.26
Performance Q
6.09
Relative Volume
0.55
Beta
0.68
Ticker: NVO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-13 | NVO | 59.56 | 0.79 | 0.47 | 1560931 |
| 2026-01-14 | NVO | 58.9 | 0.79 | 0.43 | 1585092 |
| 2026-01-15 | NVO | 57.12 | 0.80 | 1.15 | 1606497 |
| 2026-01-16 | NVO | 62.32 | 0.84 | 0.42 | 1693378 |
| 2026-01-20 | NVO | 60.72 | 0.88 | 0.60 | 1328034 |
| 2026-01-21 | NVO | 59.32 | 0.84 | 0.64 | 1361008 |
| 2026-01-22 | NVO | 62.23 | 0.85 | 0.59 | 1422546 |
| 2026-01-23 | NVO | 62.27 | 0.87 | 0.35 | 1450815 |
| 2026-01-26 | NVO | 63.98 | 0.88 | 0.52 | 1371791 |
| 2026-01-27 | NVO | 62.82 | 0.87 | 0.58 | 1396499 |
| 2026-01-28 | NVO | 60.35 | 0.88 | 0.44 | 1409720 |
| 2026-01-29 | NVO | 59.33 | 0.88 | 1.23 | 1429014 |
| 2026-01-30 | NVO | 59.45 | 0.89 | 0.63 | 1450169 |
| 2026-02-02 | NVO | 58.94 | 0.84 | 0.80 | 1346822 |
| 2026-02-03 | NVO | 50.33 | 0.85 | 0.69 | 1372674 |
| 2026-02-04 | NVO | 47.23 | 0.88 | 0.63 | 1409799 |
| 2026-02-05 | NVO | 43.36 | 0.86 | 0.66 | 1469645 |
| 2026-02-06 | NVO | 47.68 | 0.80 | 0.73 | 1554469 |
| 2026-02-09 | NVO | 49.37 | 0.84 | 0.55 | 1474904 |
| 2026-02-10 | NVO | 49.1 | 0.84 | 0.39 | 1500076 |
| 2026-02-11 | NVO | 48.7 | 0.84 | 0.57 | 1520168 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-13 | NVO | 59.63 | -8.3 | -2122.6 | 23.03 |
| 2026-01-14 | NVO | 58.92 | -8.3 | -2556.0 | 23.03 |
| 2026-01-15 | NVO | 57.12 | -8.3 | -2882.1 | 23.03 |
| 2026-01-16 | NVO | 62.35 | -8.3 | -497.6 | 23.03 |
| 2026-01-20 | NVO | 60.67 | -7.9 | -2278.8 | 23.03 |
| 2026-01-21 | NVO | 59.33 | -7.9 | -2725.3 | 23.03 |
| 2026-01-22 | NVO | 62.22 | -7.9 | -1016.4 | 23.03 |
| 2026-01-23 | NVO | 62.24 | -7.9 | -2170.9 | 23.03 |
| 2026-01-26 | NVO | 63.99 | -6.4 | -2069.7 | 23.03 |
| 2026-01-27 | NVO | 62.89 | -6.4 | -2266.5 | 23.03 |
| 2026-01-28 | NVO | 60.34 | -6.9 | -2891.8 | 23.03 |
| 2026-01-29 | NVO | 59.33 | -6.9 | -2606.4 | 23.03 |
| 2026-01-30 | NVO | 59.44 | -6.9 | -2020.1 | 23.03 |
| 2026-02-02 | NVO | 58.97 | -6.9 | -2126.3 | 23.03 |
| 2026-02-03 | NVO | 50.35 | -6.9 | -5065.2 | 23.03 |
| 2026-02-04 | NVO | 47.25 | -6.9 | -2943.5 | 23.03 |
| 2026-02-05 | NVO | 43.34 | -22.7 | -52.4 | 22.37 |
| 2026-02-06 | NVO | 47.68 | -22.7 | 3960.9 | 22.37 |
| 2026-02-09 | NVO | 49.37 | -23.9 | 1824.9 | 21.51 |
| 2026-02-10 | NVO | 49.10 | -24.4 | -2394.3 | 21.12 |
| 2026-02-11 | NVO | 48.73 | -24.4 | -2743.2 | 21.12 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-13 | NVO | 0 | -1.33 | 0.96 |
| 2026-01-14 | NVO | 0 | -1.33 | 0.96 |
| 2026-01-15 | NVO | 0 | -1.33 | 0.96 |
| 2026-01-16 | NVO | 0 | -1.33 | 0.96 |
| 2026-01-20 | NVO | 0 | -1.66 | 0.96 |
| 2026-01-21 | NVO | 0 | -1.66 | 0.96 |
| 2026-01-22 | NVO | 0 | -1.66 | 0.96 |
| 2026-01-23 | NVO | 0 | -1.66 | 0.96 |
| 2026-01-26 | NVO | 0 | -1.52 | 0.96 |
| 2026-01-27 | NVO | 0 | -1.52 | 0.96 |
| 2026-01-28 | NVO | 0 | -1.52 | 0.84 |
| 2026-01-29 | NVO | 0 | -1.52 | 0.84 |
| 2026-01-30 | NVO | 0 | -1.52 | 0.84 |
| 2026-02-02 | NVO | 0 | -1.57 | 0.84 |
| 2026-02-03 | NVO | 0 | -1.57 | 0.84 |
| 2026-02-04 | NVO | 0 | -1.57 | 0.84 |
| 2026-02-05 | NVO | 0 | -1.57 | 0.84 |
| 2026-02-06 | NVO | 0 | -1.57 | 0.84 |
| 2026-02-09 | NVO | 0 | -1.17 | 0.84 |
| 2026-02-10 | NVO | 0 | -1.17 | 0.84 |
| 2026-02-11 | NVO | 0 | -1.17 | 0.94 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1
Avg. EPS Est. Current Quarter
4.94
Avg. EPS Est. Next Quarter
5.17
Insider Transactions
Institutional Transactions
-1.17
Beta
0.68
Average Sales Estimate Current Quarter
74945
Average Sales Estimate Next Quarter
70920
Fair Value
51.55
Quality Score
98
Growth Score
90
Sentiment Score
35
Actual DrawDown %
67.1
Max Drawdown 5-Year %
-69.6
Target Price
58.65
P/E
14.05
Forward P/E
13.95
PEG
7.42
P/S
3.51
P/B
7.1
P/Free Cash Flow
18.35
EPS
3.47
Average EPS Est. Cur. Y
21.12
EPS Next Y. (Est.)
22.17
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
33.03
Relative Volume
0.55
Return on Equity vs Sector %
24.9
Return on Equity vs Industry %
16.6
EPS 1 7Days Diff
-1.2
EPS 1 30Days Diff
-0.56
EBIT Estimation
-2743.2
Novo Nordisk A/SSector: Healthcare
Industry: Drug Manufacturers - General
Employees: 68794
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
stock quote shares NVO – Novo Nordisk A/S Stock Price stock today
news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025
marketwatch NVO – Novo Nordisk A/S yahoo finance google finance
stock history NVO – Novo Nordisk A/S invest stock market
stock prices NVO premarket after hours
ticker NVO fair value insiders trading